GlassScriptPhysician profile
Ilja Faibussowitsch
NPI 1740220193
$10,422.89
in general payments reported to CMS, 2019-2025
38 companies · $2,339 in 2025
The $2,339 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,139 · 2020: $647 · 2021: $353 · 2022: $1,079 · 2023: $2,165 · 2024: $701 · 2025: $2,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,829 · Consulting Fee: $2,020 · Travel and Lodging: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,828.57 |
| Consulting Fee | $2,020.00 |
| Travel and Lodging | $356.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,139.90 | 2023 | Starling System, Hillrom - Vest System Model 105 Home Care |
| Astrazeneca Pharmaceuticals LP | $1,137.03 | 2019-2025 | Tezspire, Fasenra |
| Electromed, INC. | $1,012.23 | 2019-2025 | Smartvest |
| Olympus Corporation of The Americas | $941.90 | 2019 | |
| Verathon INC. | $900.00 | 2025 | Bronchoscope |
| Glaxosmithkline, LLC. | $895.27 | 2019-2025 | Nucala, Trelegy Ellipta |
| Insmed, INC. | $529.16 | 2019-2025 | Arikayce |
| Genzyme Corporation | $499.15 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $466.10 | 2019-2025 | Ofev |
| Philips North America LLC | $449.26 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy, Patient Interface Software |
| Intuitive Surgical, INC. | $447.13 | 2023-2024 | Da Vinci Surgical System |
| Regeneron Healthcare Solutions, INC. | $443.52 | 2022-2025 | Dupixent |
| Genentech USA, INC. | $204.66 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $199.69 | 2019-2020 | |
| Mylan Specialty L.P. | $195.56 | 2019-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $119.49 | 2019 | |
| Avanir Pharmaceuticals, INC. | $103.36 | 2019 | |
| Inspire Medical Systems, INC. | $77.89 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $70.95 | 2022-2025 | Wakix |
| Merck Sharp & Dohme LLC | $61.25 | 2019-2025 | Zerbaxa |
| Circassia INC. | $51.23 | 2019 | |
| Shionogi INC | $47.10 | 2025 | Fetroja |
| Takeda Pharmaceuticals U.S.A., INC. | $45.40 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $45.11 | 2019-2020 | |
| Inogen, INC. | $40.60 | 2022 | |
| Pfizer INC. | $39.41 | 2019 | |
| Advanced Respiratory, INC | $37.61 | 2020 | |
| Verona Pharma, INC. | $33.82 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $25.07 | 2023 | Tyvaso |
| Paratek Pharmaceuticals, INC. | $24.93 | 2024 | Nuzyra |
| Viatris Specialty LLC | $21.07 | 2025 | Yupelri |
| Grifols USA, LLC | $19.77 | 2019 | |
| Chiesi USA, INC. | $18.33 | 2022 | |
| Pulmonx Corporation | $17.94 | 2022 | |
| Amgen INC. | $16.47 | 2023 | Tezspire |
| Vanda Pharmaceuticals INC. | $16.14 | 2019 | |
| Resmed Corp | $15.33 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilja Faibussowitsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.